Published in Clin Psychol Rev on May 03, 2007
The study of fear extinction: implications for anxiety disorders. Am J Psychiatry (2011) 1.60
L-type voltage-gated calcium channels in conditioned fear: a genetic and pharmacological analysis. Learn Mem (2008) 1.57
Impaired extinction retention in adolescent rats: effects of D-cycloserine. Neuropsychopharmacology (2010) 1.45
Spacing extinction trials alleviates renewal and spontaneous recovery. Learn Behav (2009) 1.34
Enhancing exposure-based therapy from a translational research perspective. Behav Res Ther (2007) 1.24
Memory for fear extinction requires mGluR5-mediated activation of infralimbic neurons. Cereb Cortex (2010) 1.18
Cannabinoid facilitation of fear extinction memory recall in humans. Neuropharmacology (2012) 1.14
Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women. Biol Psychiatry (2012) 1.14
Catastrophic misinterpretations as a predictor of symptom change during treatment for panic disorder. J Consult Clin Psychol (2010) 1.05
Cognitive enhancers for anxiety disorders. Pharmacol Biochem Behav (2010) 1.04
D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms. Biol Psychiatry (2009) 1.04
Pharmacological enhancement of fear reduction: preclinical models. Br J Pharmacol (2011) 0.99
Sleep promotes consolidation and generalization of extinction learning in simulated exposure therapy for spider fear. J Psychiatr Res (2012) 0.99
D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders. Biol Mood Anxiety Disord (2013) 0.98
The empirical status of the "new wave" of cognitive behavioral therapy. Psychiatr Clin North Am (2010) 0.96
Threat reappraisal as a mediator of symptom change in cognitive-behavioral treatment of anxiety disorders: a systematic review. J Consult Clin Psychol (2012) 0.93
Changes in negative beliefs following three brief programs for facilitating recovery after assault. Depress Anxiety (2011) 0.92
Constraints on Enhanced Extinction Resulting from Extinction Treatment in the Presence of an Added Excitor. Learn Motiv (2009) 0.91
The birth, death and resurrection of avoidance: a reconceptualization of a troubled paradigm. Mol Psychiatry (2016) 0.86
Interpersonal Emotion Regulation Model of Mood and Anxiety Disorders. Cognit Ther Res (2014) 0.86
A stress-coping profile of opioid dependent individuals entering naltrexone treatment: a comparison with healthy controls. Psychol Addict Behav (2009) 0.85
Effect of D-cycloserine and valproic acid on the extinction of reinstated fear-conditioned responses and habituation of fear conditioning in healthy humans: a randomized controlled trial. Psychopharmacology (Berl) (2011) 0.85
Associative Accounts of Recovery-from-Extinction Effects. Learn Motiv (2014) 0.84
Sex differences in anxiety disorders: Interactions between fear, stress, and gonadal hormones. Horm Behav (2015) 0.84
Unpaired extinction: implications for treating post-traumatic stress disorder. J Psychiatr Res (2010) 0.83
Changes in comorbid conditions after prolonged exposure for PTSD: a literature review. Curr Psychiatry Rep (2015) 0.83
Toward a cognitive-behavioral classification system for mental disorders. Behav Ther (2014) 0.83
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1. Transl Psychiatry (2012) 0.83
Aberrant face and gaze habituation in fragile x syndrome. Am J Psychiatry (2014) 0.82
Categories, concepts, and conditioning: how humans generalize fear. Trends Cogn Sci (2015) 0.82
Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans. Neurobiol Learn Mem (2013) 0.81
PTSD not an anxiety disorder? DSM committee proposal turns back the hands of time. Depress Anxiety (2011) 0.81
Effects of extinction on classical conditioning and conditioning-specific reflex modification of rabbit heart rate. Behav Brain Res (2009) 0.81
A Primer on Bayesian Analysis for Experimental Psychopathologists. J Exp Psychopathol (2017) 0.81
Does fear reactivity during exposure predict panic symptom reduction? J Consult Clin Psychol (2012) 0.80
D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse. Depress Anxiety (2014) 0.80
Developmental rodent models of fear and anxiety: from neurobiology to pharmacology. Br J Pharmacol (2014) 0.80
Animal to human translational paradigms relevant for approach avoidance conflict decision making. Behav Res Ther (2017) 0.79
Individual differences in cognitive reappraisal usage modulate the time course of brain activation during symptom provocation in specific phobia. Biol Mood Anxiety Disord (2013) 0.79
Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research. Biol Psychol (2014) 0.78
Classical conditioning and conditioning-specific reflex modification of rabbit heart rate as a function of unconditioned stimulus location. Behav Neurosci (2011) 0.78
Rapid plasticity in the prefrontal cortex during affective associative learning. PLoS One (2014) 0.78
Longitudinal course of anxiety sensitivity and PTSD symptoms in cognitive-behavioral therapies for PTSD. J Anxiety Disord (2013) 0.78
Reaching new heights: comparing interpretation bias modification to exposure therapy for extreme height fear. J Consult Clin Psychol (2014) 0.78
Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior. Neurobiol Learn Mem (2013) 0.78
Expanding the intertrial interval during extinction: response cessation and recovery. Behav Ther (2009) 0.77
Associations Between Specific Negative Emotions and DSM-5 PTSD Among a National Sample of Interpersonal Trauma Survivors. J Interpers Violence (2015) 0.76
Therapeutic Effects of Extinction Learning as a Model of Exposure Therapy in Rats. Neuropsychopharmacology (2016) 0.76
A rare case of alektorophobia treated successfully with graded exposure therapy. Ind Psychiatry J (2017) 0.75
Mothers do it differently: reproductive experience alters fear extinction in female rats and women. Transl Psychiatry (2016) 0.75
Understanding the Relationship between Trauma Exposure and Depression among Adolescents after Earthquake: The Roles of Fear and Resilience. Front Psychol (2016) 0.75
High Current Anxiety Symptoms, But Not a Past Anxiety Disorder Diagnosis, are Associated with Impaired Fear Extinction. Front Psychol (2016) 0.75
Affective lability and difficulties with regulation are differentially associated with amygdala and prefrontal response in women with Borderline Personality Disorder. Psychiatry Res (2016) 0.75
Teaching Trauma-Focused Exposure Therapy for PTSD: Critical Clinical Lessons for Novice Exposure Therapists. Psychol Trauma (2011) 0.75
Nothing is safe: Intolerance of uncertainty is associated with compromised fear extinction learning. Biol Psychol (2016) 0.75
Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders. Am J Med Genet B Neuropsychiatr Genet (2016) 0.75
Neuroenhancement of Exposure Therapy in Anxiety Disorders. AIMS Neurosci (2015) 0.75
Differential Effects of Controllable Stress Exposure on Subsequent Extinction Learning in Adult Rats. Front Behav Neurosci (2016) 0.75
The Influence of State Anxiety on Fear Discrimination and Extinction in Females. Front Psychol (2017) 0.75
Efficacy and mechanisms of imagery rescripting and imaginal exposure for nightmares: study protocol for a randomized controlled trial. Trials (2016) 0.75
Trait Anxiety Modulates Brain Activity during Performance of Verbal Fluency Tasks. Front Behav Neurosci (2016) 0.75
An integrative review of attention biases and their contribution to treatment for anxiety disorders. Front Psychol (2015) 0.75
Repeated trauma exposure does not impair distress reduction during imaginal exposure for posttraumatic stress disorder. Depress Anxiety (2016) 0.75
Mindfulness-Based Interventions for Anxiety and Depression. Psychiatr Clin North Am (2017) 0.75
Generalized expectancies for internal versus external control of reinforcement. Psychol Monogr (1966) 9.97
Extinction learning in humans: role of the amygdala and vmPFC. Neuron (2004) 8.63
Neurons in medial prefrontal cortex signal memory for fear extinction. Nature (2002) 8.43
Emotional processing of fear: exposure to corrective information. Psychol Bull (1986) 8.03
Fears, phobias, and preparedness: toward an evolved module of fear and fear learning. Psychol Rev (2001) 7.13
Context and behavioral processes in extinction. Learn Mem (2004) 6.99
Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull (1993) 6.87
The role of the amygdala in fear and anxiety. Annu Rev Neurosci (1992) 6.41
Non-associative fear acquisition: a review of the evidence from retrospective and longitudinal research. Behav Res Ther (2002) 5.61
Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry (2004) 5.26
Behavioral and neural analysis of extinction. Neuron (2002) 4.53
Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci (2002) 4.52
Pavlovian conditioning. It's not what you think it is. Am Psychol (1988) 4.45
A contemporary learning theory perspective on the etiology of anxiety disorders: it's not what you thought it was. Am Psychol (2006) 3.81
Activation of the left amygdala to a cognitive representation of fear. Nat Neurosci (2001) 3.71
A modern learning theory perspective on the etiology of panic disorder. Psychol Rev (2001) 3.59
Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry (2006) 3.45
Reinstatement of fear to an extinguished conditioned stimulus. J Exp Psychol Anim Behav Process (1975) 3.41
Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci (1992) 3.40
Fear conditioning enhances different temporal components of tone-evoked spike trains in auditory cortex and lateral amygdala. Neuron (1997) 3.26
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry (2002) 3.15
A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol (1999) 3.08
Two different lateral amygdala cell populations contribute to the initiation and storage of memory. Nat Neurosci (2001) 2.82
Role of conditioned contextual stimuli in reinstatement of extinguished fear. J Exp Psychol Anim Behav Process (1979) 2.78
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry (2006) 2.77
Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci (2003) 2.39
Anxiety sensitivity and panic disorder. Biol Psychiatry (2002) 2.37
The conditioning theory of fear-acquisition: a critical examination. Behav Res Ther (1977) 2.31
Extending animal models of fear conditioning to humans. Biol Psychol (2006) 2.31
Theories of associative learning in animals. Annu Rev Psychol (2001) 2.28
Uncontrollability and unpredictability in post-traumatic stress disorder: an animal model. Psychol Bull (1992) 2.13
The stressor criterion in DSM-IV posttraumatic stress disorder: an empirical investigation. Biol Psychiatry (2001) 2.06
Cognitive mediation of treatment change in social phobia. J Consult Clin Psychol (2004) 1.95
D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behav Neurosci (2004) 1.75
Causal reasoning in rats. Science (2006) 1.73
One-Session treatment of specific phobias in youths: a randomized clinical trial. J Consult Clin Psychol (2001) 1.70
Basic emotions, relations among emotions, and emotion-cognition relations. Psychol Rev (1992) 1.50
Lower precombat intelligence is a risk factor for posttraumatic stress disorder. J Consult Clin Psychol (1998) 1.46
Reinstatement of fear responses in human aversive conditioning. Behav Res Ther (2005) 1.44
Emotional conditioning to masked stimuli: expectancies for aversive outcomes following nonrecognized fear-relevant stimuli. J Exp Psychol Gen (1998) 1.43
Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol (1997) 1.36
Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications. Learn Mem (2004) 1.31
Self-focused attention before and after treatment of social phobia. Behav Res Ther (2000) 1.28
Social phobia: an analysis of possible developmental factors. J Abnorm Psychol (1995) 1.27
Protection from extinction in human fear conditioning. Behav Res Ther (2000) 1.24
Changes in self-perception during treatment of social phobia. J Consult Clin Psychol (2004) 1.20
Context-specificity of relapse: effects of therapist and environmental context on return of fear. Behav Res Ther (1999) 1.17
Preparedness and phobias: a review. Psychol Bull (1987) 1.12
Reinstatement of extinguished conditioned responses and negative stimulus valence as a pathway to return of fear in humans. Learn Mem (2004) 1.11
Treatment of severe social phobia: effects of guided exposure with and without cognitive restructuring. J Consult Clin Psychol (1988) 1.11
Effects of potentially phobic conditioned stimuli on retention, reconditioning, and extinction of the conditioned skin conductance response. Psychophysiology (1991) 1.07
On nonassociative fear emergence. Behav Res Ther (2002) 0.99
Modeling processes in the acquisition of fears: vicarious electrodermal conditioning to fear-relevant stimuli. J Pers Soc Psychol (1978) 0.98
Cognitive processes in extinction. Learn Mem (2004) 0.96
Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry (1991) 0.96
The role of contingency in classical conditioning. Psychol Rev (1990) 0.92
Extinction: new excitement for an old phenomenon. Biol Psychiatry (2006) 0.92
Social phobia: a comparative evaluation of cognitive and behavioral interventions. Behav Res Ther (1985) 0.91
Acquisition of phobias and anxiety response patterns in clinical patients. Behav Res Ther (1981) 0.89
Cognitive and behavioural treatments of fear of blushing, sweating or trembling. Behav Res Ther (1993) 0.89
Exposure and anxiety management in the treatment of social phobia. J Consult Clin Psychol (1984) 0.88
Greater resistance to extinction of electrodermal responses conditioned to potentially phobic CSs: a noncognitive process? Psychophysiology (1986) 0.87
The etiology and maintenance of severe animal phobias. Behav Res Ther (1985) 0.86
Exposure with and without cognitive therapy for generalized social phobia: effects of individual and group treatment. Behav Res Ther (1993) 0.86
A demonstration of acute hyperventilation during naturally occurring panic attacks. Behav Res Ther (1986) 0.85
Conditioning theory: a model for the etiology of public speaking anxiety? Behav Res Ther (1995) 0.85
A meta-analysis of treatments for panic disorder. J Consult Clin Psychol (1993) 0.84
The onset of contingency awareness and electrodermal classical conditioning: an analysis of temporal relationships during acquisition and extinction. Psychophysiology (1977) 0.83
Danger expectancies, self-efficacy and insight in spider phobia. Behav Res Ther (2000) 0.83
Cognitive factors in electrodermal conditioning. Psychol Bull (1973) 0.83
The passing of the two-stage theory of fear and avoidance: fresh possibilities. Behav Res Ther (1976) 0.82
Phobias and preparedness: phobic versus neutral pictures as conditioned stimuli for human autonomic responses. J Abnorm Psychol (1975) 0.81
Processing of phobic stimuli and its relationship to outcome. Behav Res Ther (2000) 0.80
Acquisition of agoraphobia, mode of onset and anxiety response patterns. Behav Res Ther (1983) 0.78
Anxiety response patterns and etiological factors in dog-fearful and non-fearful subjects. Behav Res Ther (1988) 0.77